JP3728738B1 - Rumen bypass for ruminants - Google Patents
Rumen bypass for ruminants Download PDFInfo
- Publication number
- JP3728738B1 JP3728738B1 JP2004335286A JP2004335286A JP3728738B1 JP 3728738 B1 JP3728738 B1 JP 3728738B1 JP 2004335286 A JP2004335286 A JP 2004335286A JP 2004335286 A JP2004335286 A JP 2004335286A JP 3728738 B1 JP3728738 B1 JP 3728738B1
- Authority
- JP
- Japan
- Prior art keywords
- acid
- rumen
- salt
- agent
- ruminants
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 210000004767 rumen Anatomy 0.000 title claims abstract description 60
- 241000282849 Ruminantia Species 0.000 title claims abstract description 36
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 58
- 150000003839 salts Chemical class 0.000 claims abstract description 30
- 229940088623 biologically active substance Drugs 0.000 claims abstract description 26
- -1 unsaturated aliphatic monocarboxylic acids Chemical class 0.000 claims abstract description 24
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000003755 preservative agent Substances 0.000 claims abstract description 20
- 230000002335 preservative effect Effects 0.000 claims abstract description 20
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000001993 wax Substances 0.000 claims abstract description 18
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 17
- 239000000787 lecithin Substances 0.000 claims abstract description 17
- 229940067606 lecithin Drugs 0.000 claims abstract description 17
- 235000010445 lecithin Nutrition 0.000 claims abstract description 17
- LLEMOWNGBBNAJR-UHFFFAOYSA-N biphenyl-2-ol Chemical compound OC1=CC=CC=C1C1=CC=CC=C1 LLEMOWNGBBNAJR-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000011248 coating agent Substances 0.000 claims abstract description 14
- 229920006395 saturated elastomer Polymers 0.000 claims abstract description 13
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 12
- 235000019260 propionic acid Nutrition 0.000 claims abstract description 10
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims abstract description 10
- 239000005711 Benzoic acid Substances 0.000 claims abstract description 9
- 235000010233 benzoic acid Nutrition 0.000 claims abstract description 9
- 239000003925 fat Substances 0.000 claims abstract description 9
- 239000004287 Dehydroacetic acid Substances 0.000 claims abstract description 8
- 239000002253 acid Substances 0.000 claims abstract description 8
- 235000019258 dehydroacetic acid Nutrition 0.000 claims abstract description 8
- 229940061632 dehydroacetic acid Drugs 0.000 claims abstract description 8
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 claims abstract description 8
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 claims abstract description 8
- 235000010199 sorbic acid Nutrition 0.000 claims abstract description 8
- 239000004334 sorbic acid Substances 0.000 claims abstract description 8
- 229940075582 sorbic acid Drugs 0.000 claims abstract description 8
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 8
- 241001465754 Metazoa Species 0.000 claims abstract description 7
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 claims abstract description 7
- 235000010292 orthophenyl phenol Nutrition 0.000 claims abstract description 7
- 239000004306 orthophenyl phenol Substances 0.000 claims abstract description 7
- 235000019871 vegetable fat Nutrition 0.000 claims abstract description 7
- 235000010290 biphenyl Nutrition 0.000 claims abstract description 6
- 239000004305 biphenyl Substances 0.000 claims abstract description 6
- 125000006267 biphenyl group Chemical group 0.000 claims abstract description 6
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000004308 thiabendazole Substances 0.000 claims abstract description 6
- 235000010296 thiabendazole Nutrition 0.000 claims abstract description 6
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229960004546 thiabendazole Drugs 0.000 claims abstract description 6
- UQPLZHUFLPDORW-UHFFFAOYSA-N 2-phenylphenol;sodium Chemical compound [Na].OC1=CC=CC=C1C1=CC=CC=C1 UQPLZHUFLPDORW-UHFFFAOYSA-N 0.000 claims abstract description 5
- 150000002148 esters Chemical class 0.000 claims abstract description 5
- 239000002245 particle Substances 0.000 claims description 29
- 235000021355 Stearic acid Nutrition 0.000 claims description 14
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 14
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 14
- 239000003921 oil Substances 0.000 claims description 14
- 239000008117 stearic acid Substances 0.000 claims description 14
- 239000008199 coating composition Substances 0.000 claims description 11
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 claims description 10
- 229960005337 lysine hydrochloride Drugs 0.000 claims description 10
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 9
- 229930195729 fatty acid Natural products 0.000 claims description 9
- 239000000194 fatty acid Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 235000019197 fats Nutrition 0.000 claims description 7
- 235000010294 sodium orthophenyl phenol Nutrition 0.000 claims description 4
- 239000004307 sodium orthophenyl phenol Substances 0.000 claims description 4
- 230000002421 anti-septic effect Effects 0.000 claims 1
- 244000005700 microbiome Species 0.000 abstract description 16
- 210000003165 abomasum Anatomy 0.000 abstract description 10
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 7
- 239000010775 animal oil Substances 0.000 abstract description 3
- 239000008158 vegetable oil Substances 0.000 abstract description 3
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 8
- BCZXFFBUYPCTSJ-UHFFFAOYSA-L Calcium propionate Chemical compound [Ca+2].CCC([O-])=O.CCC([O-])=O BCZXFFBUYPCTSJ-UHFFFAOYSA-L 0.000 description 7
- 235000010331 calcium propionate Nutrition 0.000 description 7
- 239000004330 calcium propionate Substances 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 210000004051 gastric juice Anatomy 0.000 description 7
- 235000019484 Rapeseed oil Nutrition 0.000 description 6
- 239000013543 active substance Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 6
- 229910000019 calcium carbonate Inorganic materials 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000001681 protective effect Effects 0.000 description 5
- 241000283690 Bos taurus Species 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 239000000155 melt Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 240000002791 Brassica napus Species 0.000 description 3
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 229960003080 taurine Drugs 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 235000019733 Fish meal Nutrition 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000004467 fishmeal Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 210000003750 lower gastrointestinal tract Anatomy 0.000 description 2
- 239000012803 melt mixture Substances 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 235000015424 sodium Nutrition 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- JXKPEJDQGNYQSM-UHFFFAOYSA-M sodium propionate Chemical compound [Na+].CCC([O-])=O JXKPEJDQGNYQSM-UHFFFAOYSA-M 0.000 description 2
- 235000010334 sodium propionate Nutrition 0.000 description 2
- 239000004324 sodium propionate Substances 0.000 description 2
- 229960003212 sodium propionate Drugs 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- PBBGSZCBWVPOOL-HDICACEKSA-N 4-[(1r,2s)-1-ethyl-2-(4-hydroxyphenyl)butyl]phenol Chemical compound C1([C@H](CC)[C@H](CC)C=2C=CC(O)=CC=2)=CC=C(O)C=C1 PBBGSZCBWVPOOL-HDICACEKSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 239000005996 Blood meal Substances 0.000 description 1
- 235000019743 Choline chloride Nutrition 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 239000004288 Sodium dehydroacetate Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229940077731 carbohydrate nutrients Drugs 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 1
- 229960003178 choline chloride Drugs 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- RGLYKWWBQGJZGM-ISLYRVAYSA-N diethylstilbestrol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(\CC)C1=CC=C(O)C=C1 RGLYKWWBQGJZGM-ISLYRVAYSA-N 0.000 description 1
- 229960000452 diethylstilbestrol Drugs 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 235000013905 glycine and its sodium salt Nutrition 0.000 description 1
- 229950001996 hexestrol Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 description 1
- 229960005287 lincomycin Drugs 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 229940041033 macrolides Drugs 0.000 description 1
- 230000018984 mastication Effects 0.000 description 1
- 238000010077 mastication Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- 235000006109 methionine Nutrition 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000019259 sodium dehydroacetate Nutrition 0.000 description 1
- 229940079839 sodium dehydroacetate Drugs 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 1
- WSWCOQWTEOXDQX-MQQKCMAXSA-N sorbic acid group Chemical group C(\C=C\C=C\C)(=O)O WSWCOQWTEOXDQX-MQQKCMAXSA-N 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 229960002898 threonine Drugs 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
- 235000021081 unsaturated fats Nutrition 0.000 description 1
- 229960004295 valine Drugs 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Feed For Specific Animals (AREA)
- Fodder In General (AREA)
Abstract
【課題】
生物学的活性物質を微生物が生息している反すう動物の第1胃で安定に保護し、第4胃以降の下部消化器官で効率良く放出させることである。
【解決手段】
生物学的活性物質を、硬化した動・植物性油脂、炭素数12〜22個を有する直鎖又は分岐状の飽和又は不飽和の脂肪族モノカルボン酸、脂肪族エステル、ロウ及びワックスより選択される少なくとも1種の被覆剤と、レシチン及びプロピオン酸又はその塩、ソルビン酸又はその塩、安息香酸又はその塩、デヒドロ酢酸又はその塩、パラオキシ安息香酸エステル類、イマザリル、チアベンダゾール、オルトフェニルフェノール、オルトフェニルフェノールナトリウム及びジフェニルより選択される少なくとも1種の防腐剤で被覆することを特徴とする反すう動物用ルーメンバイパス剤。
【選択図】 なし
【Task】
The biologically active substance is stably protected in the rumen of ruminants inhabiting microorganisms, and is efficiently released in the lower digestive tract after the fourth stomach.
[Solution]
The biologically active substance is selected from hardened animal / vegetable oils and fats, linear or branched saturated or unsaturated aliphatic monocarboxylic acids having 12 to 22 carbon atoms, aliphatic esters, waxes and waxes. At least one coating agent and lecithin and propionic acid or a salt thereof, sorbic acid or a salt thereof, benzoic acid or a salt thereof, dehydroacetic acid or a salt thereof, paraoxybenzoic acid esters, imazalyl, thiabendazole, orthophenylphenol, ortho A rumen bypass agent for ruminants, which is coated with at least one preservative selected from sodium phenylphenol and diphenyl.
[Selection figure] None
Description
本発明は、反すう動物用飼料添加組成物に属する。さらに詳しくは、生物学的活性物質を反すう動物の第1胃(ルーメン)では安定に保護し、第4胃以降の下部消化器官で放出可能にする被覆組成物で被覆した、反すう動物用ルーメンバイパス剤に関する。 The present invention belongs to a feed additive composition for ruminants. More specifically, rumen bypass for ruminant animals, coated with a coating composition that stably protects the biologically active substance in the rumen rumen and releases it in the lower gastrointestinal tract after the fourth stomach. It relates to the agent.
牛などの反すう動物は、ヒトなどの単胃動物とは異なり複数の胃が存在し、その第1胃には多数の微生物が生息している。そのため、反すう動物に無処理の生物学的活性物質を経口投与しても、微生物により大部分が分解され有効利用されない。 Ruminants such as cows have a plurality of stomachs unlike monogastric animals such as humans, and a large number of microorganisms inhabit the first stomach. Therefore, even when an untreated biologically active substance is orally administered to ruminants, most of them are decomposed by microorganisms and are not effectively used.
生物学的活性物質を反すう動物の第1胃で安定に保護し、第4胃以降の下部消化器官で放出可能にする反すう動物用ルーメンバイパス剤の被覆組成物については、極めて多くの提案がなされている。しかしながら、いまだ十分な第1胃での保護性及び第4胃以降の下部消化器官での放出性を兼ね備えたルーメンバイパス剤は存在していないのが現状であった。これは、反すう動物の第1胃での保護性の評価方法及びルーメンバイパス剤の粒径あるいはコーティング層を有するなどの構造についての検討が、十分行われなかったことによると考えられる。 Numerous proposals have been made for ruminant rumen bypass coating compositions that provide stable protection of the biologically active substance in the rumen rumen and release it in the lower gastrointestinal tract after the fourth stomach. ing. However, at present, there is no rumen bypass agent that has sufficient protection in the first stomach and release in the lower digestive tract after the fourth stomach. This is considered to be due to the fact that the method for evaluating the ruminant protection in the rumen and the structure of the rumen bypass agent having a particle size or a coating layer have not been sufficiently studied.
特許文献1又は特許文献2などでは、第1胃での生物学的活性物質の保護性を、pH及び液温を調整した模擬第1胃液で評価するなど、牛などの反すう動物の特殊性である、第1胃に生息する微生物の影響が検討されていない。実際に、市販されているルーメンバイパス剤は、模擬第1胃液では高い保護性を有していたが、微生物が生息している反すう動物の第1胃液を用いて評価した結果、極端に保護性が損なわれていた。この原因としては、反すう動物の第1胃に多数生息している微生物の影響によるものと考えられる。したがって、生物学的活性物質を反すう動物の第1胃に多数生息する微生物からの影響を抑制することが可能な被覆組成物で被覆することが必要であった。 In Patent Document 1 or Patent Document 2 and the like, the protection of biologically active substances in the rumen is evaluated with simulated first gastric fluid whose pH and liquid temperature are adjusted. The influence of certain microorganisms that live in the rumen has not been studied. Actually, the commercially available rumen bypass agent had a high protective property in the simulated first gastric juice, but as a result of evaluation using the first gastric fluid of ruminants inhabiting microorganisms, it was extremely protective. Was damaged. The cause of this is thought to be due to the influence of microorganisms that live in large numbers in the rumen of ruminants. Therefore, it was necessary to coat the biologically active substance with a coating composition capable of suppressing the influence of microorganisms that live in the rumen of the ruminant.
また、特許文献3では、微生物の生息する第1胃液でルーメンバイパス剤の保護性を評価しているものの、粒径は4〜15mmと大きいため咀嚼により崩壊しやすく、さらに、このルーメンバイパス剤は2重被覆しているため、反すう咀嚼などで核表層部の被覆が破壊された場合は極端に保護効果が低下するなどの欠点があった。 Moreover, in patent document 3, although the protective property of a rumen bypass agent is evaluated with the 1st gastric fluid which microbes inhabit, since a particle size is 4-15 mm large, it is easy to disintegrate by chewing, Furthermore, this rumen bypass agent is Due to the double coating, there is a drawback that the protective effect is extremely reduced when the coating on the core surface layer is destroyed by rubbing mastication or the like.
つまり、市販のルーメンバイパス剤においては、微生物の生息する第1胃での生物学的活性物質の保護性においては十分満足できるものではない。この原因は、反すう動物特有の第1胃に生息している微生物による影響であり、この微生物の存在を考慮した上で第1胃での保護性を検討する必要があった。また、この反すう動物の第1胃に生息している微生物は、反すう動物自身の生命維持に必要なエネルギーであり、タンパク質などの栄養素となりえるため、第1胃の微生物の生息に影響を与えることなく、生物学的活性物質を保護することができる被覆組成物で被覆した反すう動物用ルーメンバイパス剤の開発が必要であったわけである。 In other words, the commercially available rumen bypass agent is not sufficiently satisfactory in the protection of biologically active substances in the rumen where microorganisms live. This is due to the influence of microorganisms that live in the rumen, which are unique to ruminants, and it was necessary to study the protection of the rumen in consideration of the presence of these microorganisms. In addition, the microorganisms that live in the rumen of ruminants are necessary for maintaining the lives of ruminants and can be nutrients such as proteins. Instead, it was necessary to develop rumen bypass agents for ruminants that were coated with a coating composition capable of protecting biologically active substances.
養牛農家は牛に有効とされる生物学的活性物質を経口投与する場合、微生物が多数生息している第1胃においても生物学的活性物質を安定に保護し、第4胃以降の下部消化器官での放出性に優れ、かつ低価格の反すう動物用ルーメンバイパス剤が供給されることを切望している。
本発明が解決しようとする課題は、生物学的活性物質を微生物の生息している反すう動物の第1胃で安定に保護し、第4胃以降の下部消化器官で効率良く放出させ、かつ低コストで製造可能な方法でルーメンバイパス剤を得ることにある。 The problem to be solved by the present invention is that the biologically active substance is stably protected in the rumen of ruminants inhabiting microorganisms, is efficiently released in the lower digestive tract after the fourth stomach, and low The object is to obtain a lumen bypass agent in a cost-manufacturable manner.
本発明者等は上記の目的を達成するため鋭意努力した結果、生物学的活性物質を、A)硬化した動物性油脂、硬化した植物性油脂、炭素数12〜22個を有する直鎖又は分岐状の飽和又は不飽和の脂肪族モノカルボン酸、脂肪酸エステル、ロウ及びワックスより選択される少なくとも1種の被覆剤、B)レシチン及びC)プロピオン酸又はその塩、ソルビン酸又はその塩、安息香酸又はその塩、デヒドロ酢酸又はその塩、パラオキシ安息香酸エステル類、イマザリル、チアベンダゾール、オルトフェニルフェノール、オルトフェニルフェノールナトリウム及びジフェニルより選択される少なくとも1種の防腐剤、よりなる被覆組成物で被覆することにより、反すう動物の第1胃での保護性(ルーメンバイパス率)を向上させることができることを見いだし、本発明を完成するに至った。 As a result of diligent efforts to achieve the above-mentioned object, the present inventors have made biologically active substances A) hardened animal fats and oils, hardened vegetable fats and oils, linear or branched having 12 to 22 carbon atoms. At least one coating agent selected from saturated saturated or unsaturated aliphatic monocarboxylic acids, fatty acid esters, waxes and waxes, B) lecithin and C) propionic acid or a salt thereof, sorbic acid or a salt thereof, benzoic acid Or coating with a coating composition comprising at least one preservative selected from salts thereof, dehydroacetic acid or salts thereof, paraoxybenzoates, imazalyl, thiabendazole, orthophenylphenol, sodium orthophenylphenol and diphenyl This can improve the rumen's rumen protection (lumen bypass rate). The finding has led to the completion of the present invention.
本発明に使用する防腐剤は、カビ、細菌など微生物の発育を抑制、又は抗菌作用を持つもので、これをルーメンバイパス剤に含有させることで、第1胃に生息する微生物による生物学的活性物質の分解やルーメンバイパス剤の表面付近への侵入を最小限に抑え、その結果、崩壊を防止する効果があるものと考えられる。また、防腐剤の添加量においては、大量に添加した場合、微生物の増殖及び発育に影響を及ぼす可能性があり、一方、少なすぎると効果が期待できない。したがって、防腐剤の含有量はルーメンバイパス剤全体の0.01〜2.0重量%が望ましい。好ましくは、0.1〜1.0重量%である。 The preservative used in the present invention suppresses the growth of microorganisms such as fungi and bacteria, or has an antibacterial action. By containing this in a rumen bypass agent, biological activity by microorganisms living in the rumen It is considered that the decomposition of the substance and the penetration of the rumen bypass agent into the vicinity of the surface are minimized, and as a result, the disintegration is prevented. In addition, when the preservative is added in a large amount, it may affect the growth and growth of microorganisms. On the other hand, if it is too small, the effect cannot be expected. Therefore, the content of the preservative is preferably 0.01 to 2.0% by weight of the whole rumen bypass agent. Preferably, it is 0.1 to 1.0% by weight.
製造方法としては、硬化した動物性油脂、硬化した植物性油脂、炭素数12〜22個を有する直鎖又は分岐状の飽和又は不飽和の脂肪族モノカルボン酸、脂肪酸エステル、ロウ及びワックスより選択される少なくとも1種の被覆剤と、レシチンを溶融混合し、その溶融混合液に生物学的活性物質及び防腐剤を分散及び/又は溶解した噴射用溶融液を空気中へ噴射する噴射造粒法である。この製造方法は、造粒する工程のみにより球状のルーメンバイパス剤を得ることができ、低コストで製造可能である。 The production method is selected from hardened animal fats and oils, hardened vegetable fats and oils, linear or branched saturated or unsaturated aliphatic monocarboxylic acids having 12 to 22 carbon atoms, fatty acid esters, waxes and waxes. A granulation method in which at least one coating agent and lecithin are melt-mixed, and a spray melt in which a biologically active substance and a preservative are dispersed and / or dissolved in the melt mixture is sprayed into the air It is. This manufacturing method can obtain a spherical lumen bypass agent only by the granulating step, and can be manufactured at low cost.
生物学的活性物質を第4胃以降の下部消化器官で放出させる点については、ルーメンバイパス剤にレシチンを含有させると良い。さらにステアリン酸を含有させることにより、第1胃での保護性及び第4胃以降の放出性が優れたルーメンバイパス剤を得ることができる。 Regarding the point of releasing the biologically active substance in the lower digestive tract after the fourth stomach, it is preferable to add lecithin to the rumen bypass agent. Furthermore, by containing stearic acid, it is possible to obtain a rumen bypass agent having excellent protection in the first stomach and excellent release from the fourth stomach.
生物学的活性物質の粒径については、小さいほど球状のルーメンバイパス剤の表面付近に存在する生物学的活性物質が減少し、被覆しやすいため、微粉物を使用することが望ましい。 Regarding the particle diameter of the biologically active substance, it is desirable to use a fine powder because the smaller the biological active substance existing near the surface of the spherical lumen bypass agent, the easier it is to coat.
生物学的活性物質の微粉物を得る手段としては、ピンミル、ボールミル又はジェットミルなどで粉砕する方法があり、平均粒径150μm以下にすることにより良好なルーメンバイパス剤が得られる。一方、平均粒径が1μm以下に微粉砕した生物学的活性物質を溶融混合液に分散させた場合、噴射用溶融液の粘度上昇により、噴射するのが困難なため、生物学的活性物質の含有率をかなり下げる必要がある。したがって、生物学的活性物質の平均粒径は1〜150μmに調整する必要がある。好ましくは、10〜100μmが望ましい。 As a means for obtaining a fine powder of a biologically active substance, there is a method of pulverizing with a pin mill, a ball mill, a jet mill or the like, and a good lumen bypass agent can be obtained by making the average particle size 150 μm or less. On the other hand, when a biologically active substance finely pulverized to an average particle size of 1 μm or less is dispersed in a molten mixture, it is difficult to inject due to an increase in viscosity of the injection melt. It is necessary to lower the content rate considerably. Therefore, it is necessary to adjust the average particle size of the biologically active substance to 1 to 150 μm. Preferably, 10-100 micrometers is desirable.
つまり本発明は、(1):生物学的活性物質を、下記のA)、B)及びC)よりなる被覆組成物で被覆する粒子において、その粒子がC)を0.01〜2.0重量%含有することを特徴とする反すう動物用ルーメンバイパス剤。A)硬化した動物性油脂、硬化した植物性油脂、炭素数12〜22個を有する直鎖又は分岐状の飽和又は不飽和の脂肪族モノカルボン酸、脂肪酸エステル、ロウ及びワックスより選択される少なくとも1種の被覆剤、B)レシチン、C)プロピオン酸又はその塩、ソルビン酸又はその塩、安息香酸又はその塩、デヒドロ酢酸又はその塩、パラオキシ安息香酸エステル類、イマザリル、チアベンダゾール、オルトフェニルフェノール、オルトフェニルフェノールナトリウム及びジフェニルより選択される少なくとも1種の防腐剤、(2):上記C)の防腐剤がプロピオン酸又はその塩であることを特徴とする請求項1記載の反すう動物用ルーメンバイパス剤、(3):生物学的活性物質が少なくともリジン塩酸塩を含有することを特徴とする請求項1又は請求項2のいずれか記載の反すう動物用ルーメンバイパス剤、(4):上記A)の被覆剤が少なくとも炭素数12〜22個を有する直鎖又は分岐状の飽和又は不飽和の脂肪族モノカルボン酸を含有することを特徴とする請求項1〜請求項3のいずれか記載の反すう動物用ルーメンバイパス剤、(5):炭素数12〜22個を有する直鎖又は分岐状の飽和又は不飽和の脂肪族モノカルボン酸がステアリン酸であることを特徴とする請求項1〜請求項4のいずれか記載の反すう動物用ルーメンバイパス剤、(6):生物学的活性物質を被覆組成物の溶融混合液中に分散及び/又は溶解した噴射用溶融液を空気中へ噴射して造粒することにより得たことを特徴とする請求項1〜請求項5のいずれか記載の反すう動物用ルーメンバイパス剤、(7):請求項1〜請求項6のいずれか記載の反すう動物用ルーメンバイパス剤を含有する飼料、に関する。
That is, the present invention relates to (1): particles in which a biologically active substance is coated with a coating composition comprising the following A), B) and C) , wherein the particles contain 0.01 to 2.0% by weight of C). A rumen bypass agent for ruminants characterized by this. A) at least selected from hardened animal fats, hardened vegetable fats and oils, linear or branched saturated or unsaturated aliphatic monocarboxylic acids having 12 to 22 carbon atoms, fatty acid esters, waxes and waxes One coating agent, B) lecithin, C) propionic acid or a salt thereof, sorbic acid or a salt thereof, benzoic acid or a salt thereof, dehydroacetic acid or a salt thereof, paraoxybenzoic acid esters, imazalyl, thiabendazole, orthophenylphenol, The rumen bypass for ruminants according to claim 1, characterized in that at least one preservative selected from sodium orthophenylphenol and diphenyl, (2): the preservative of C) is propionic acid or a salt thereof. Agent (3): the biologically active substance contains at least lysine hydrochloride The rumen bypass agent for ruminants according to any one of claims 1 and 2, (4): a linear or branched saturated or unsaturated fat in which the coating agent of A) has at least 12 to 22 carbon atoms. A rumen bypass agent for ruminants according to any one of claims 1 to 3, which contains an aliphatic monocarboxylic acid, (5): linear or branched saturated having 12 to 22 carbon atoms The rumen bypass agent for ruminants according to any one of claims 1 to 4, wherein the unsaturated aliphatic monocarboxylic acid is stearic acid, (6): coating composition of biologically active substance The ruminant according to any one of claims 1 to 5, wherein the ruminant is obtained by injecting and granulating an injection melt, which is dispersed and / or dissolved in a molten mixture of products, into the air. Lumen bypass agent (7): feed containing ruminant lumen bypassing agent according to any one of claims 1 to 6, relates.
以上説明したように、生物学的活性物質を、A)硬化した動物性油脂、硬化した植物性油脂、炭素数12〜22個を有する直鎖又は分岐状の飽和又は不飽和の脂肪族モノカルボン酸、脂肪酸エステル、ロウ及びワックスより選択される少なくとも1種の被覆剤、B)レシチン及びC)プロピオン酸又はその塩、ソルビン酸又はその塩、安息香酸又はその塩、デヒドロ酢酸又はその塩、パラオキシ安息香酸エステル類、イマザリル、チアベンダゾール、オルトフェニルフェノール、オルトフェニルフェノールナトリウム及びジフェニルより選択される少なくとも1種の防腐剤、よりなる被覆組成物で被覆することにより、反すう動物の第1胃の保護性、第4胃以降の下部消化器官での放出性に優れたルーメンバイパス剤を提供するものであり、産業上の意義は極めて大きい。 As explained above, the biologically active substance is: A) hardened animal oil, hardened vegetable oil, straight chain or branched saturated or unsaturated aliphatic monocarboxylic acid having 12 to 22 carbon atoms At least one coating agent selected from acids, fatty acid esters, waxes and waxes, B) lecithin and C) propionic acid or salts thereof, sorbic acid or salts thereof, benzoic acid or salts thereof, dehydroacetic acid or salts thereof, paraoxy Protecting ruminant rumen by coating with a coating composition comprising at least one preservative selected from benzoates, imazalyl, thiabendazole, orthophenylphenol, orthophenylphenol sodium and diphenyl , Providing a lumen bypass agent excellent in release in the lower digestive tract after the fourth stomach, Significance on the work is very large.
本発明において、生物学的活性物質としては、アミノ酸類、ビタミン類、酵素類、炭水化物類、天然物及び医薬品類などから選ばれた少なくとも1種または2種以上の混合物が使用できる。 In the present invention, as the biologically active substance, at least one kind or a mixture of two or more kinds selected from amino acids, vitamins, enzymes, carbohydrates, natural products and pharmaceuticals can be used.
具体的には、アミノ酸類としては、アミノ酢酸、アラニン、アルギニン、リジン、グルタミン酸ナトリウム、メチオニン、トリプトファン、トレオニン、バリン、ベタイン、タウリンなどのアミノ酸及びアミノ酸誘導体など;ビタミン類としてはビタミンA、ビタミンD、ビタミンE、ビタミンC、ビタミンB1、ビタミンB2、ビタミンB6、ビタミンB12、塩化コリン、パントテン酸カルシウム、ニコチン酸、ニコチン酸アミド、ビオチン、葉酸など;酵素類としてはプロテアーゼ、アミラーゼ、リパーゼ、混合酵素など;炭水化物としては澱粉、ショ糖、ブドウ糖など、天然物としては魚粉、海草粉、血粉、穀物粉、胆汁末など;医薬品類としては抗生物質及びホルモン剤などがあり、その抗生物質としてはアミノグリコシド系、テトラサイクリン系、ペニシリン系、マクロライド系、リンコマイシン系などが挙げられ、ホルモン剤としてはエストロジェン、スチルベストロール、ヘキセストロールなどが挙げられる。 Specifically, amino acids include aminoacetic acid, alanine, arginine, lysine, sodium glutamate, methionine, tryptophan, threonine, valine, betaine, taurine, etc .; vitamins such as vitamin A and vitamin D , Vitamin E, vitamin C, vitamin B1, vitamin B2, vitamin B6, vitamin B12, choline chloride, calcium pantothenate, nicotinic acid, nicotinic acid amide, biotin, folic acid, etc .; enzymes include protease, amylase, lipase, mixed enzyme Carbohydrates include starch, sucrose, and glucose; natural products such as fish meal, seaweed powder, blood meal, cereal meal, and bile powder; pharmaceuticals include antibiotics and hormones; System, Te Rasaikurin system, penicillins, macrolides, such as lincomycin system. Examples of the hormone drug estrogen, stilbestrol and hexestrol, and the like.
被覆剤において、硬化した動物性油脂としては、牛脂、豚脂など、硬化した植物性油脂としては、パーム硬化油、ダイズ硬化油、ナタネ硬化油、ヒマシ硬化油など、炭素数12〜22個を有する直鎖又は分岐状の飽和又は不飽和の脂肪族モノカルボン酸としては、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、オレイン酸、リノール酸など、脂肪酸エステルとしては、グリセリン脂肪酸エステル、ショ糖脂肪酸エステルなど、ロウ類としては、カルナバロウ、蜜ロウなど、ワックス類としては天然ワックス、合成ワックス、パラフィンワックスなどが使用できる。 In the coating agent, as the hardened animal fats and oils, beef tallow, pork fat and the like, and as the hardened vegetable fats and oils, palm hardened oil, soybean hardened oil, rapeseed hardened oil, castor hardened oil and the like have 12 to 22 carbon atoms. Examples of the linear or branched saturated or unsaturated aliphatic monocarboxylic acid include lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, linoleic acid, etc., and fatty acid esters include glycerin fatty acid ester, sucrose Examples of waxes that can be used include fatty acid esters such as carnauba wax and beeswax, and waxes that can be used include natural wax, synthetic wax, and paraffin wax.
防腐剤において、プロピオン酸又はその塩としては、プロピオン酸、プロピオン酸カルシウム、プロピオン酸ナトリウム、ソルビン酸又はその塩としては、ソルビン酸、ソルビン酸カリウム、安息香酸又はその塩としては、安息香酸、安息香酸ナトリウム、デヒドロ酢酸又はその塩としては、デヒドロ酢酸、デヒドロ酢酸ナトリウム、パラオキシ安息香酸エステル類としては、パラオキシ安息香酸イソブチル、パラオキシ安息香酸イソプロピル、パラオキシ安息香酸エチル、パラオキシ安息香酸ブチル、パラオキシ安息香酸プロピルが使用できる。 In the preservative, propionic acid or its salt is propionic acid, calcium propionate, sodium propionate, sorbic acid or its salt is sorbic acid, potassium sorbate, benzoic acid or its salt is benzoic acid, benzoic acid Examples of sodium acid, dehydroacetic acid or salts thereof include dehydroacetic acid, sodium dehydroacetate, and paraoxybenzoic acid esters such as isobutyl paraoxybenzoate, isopropyl paraoxybenzoate, ethyl paraoxybenzoate, butyl paraoxybenzoate, and propyl paraoxybenzoate Can be used.
さらに必要であれば、比重調整剤として炭酸カルシウム、リン酸カルシウム、タルクなどを使用して比重を調整してもよい。 If necessary, the specific gravity may be adjusted by using calcium carbonate, calcium phosphate, talc or the like as a specific gravity adjusting agent.
また、噴射造粒で得たルーメンバイパス剤をリボンミキサーなどの混合機で脱脂米ぬか、小麦粉、乾燥オカラ、とうもろこし及び/又は魚粉などの原材料と均一に混合し、飼料とすることもできる。 Further, the rumen bypass agent obtained by spray granulation can be uniformly mixed with raw materials such as defatted rice bran, wheat flour, dried okara, corn and / or fish meal with a mixer such as a ribbon mixer to obtain a feed.
本発明をさらに詳細に説明する。本発明は以下の実施例より何ら制限を受けるものではない。 The present invention will be described in further detail. The present invention is not limited in any way by the following examples.
本発明のルーメンバイパス剤としての評価は以下の方法で行った。
(第1胃の保護性の評価)牛の口より第1胃の中層から下層付近まで管を通し、第1胃液を吸引して得る。第1胃液を得た後、直ちにルーメンバイパス剤を第1胃液900mLに浸漬し40℃で16時間攪拌する。攪拌後、この試験に供したルーメンバイパス剤をすべて回収して生物学的活性物質の残存率(ルーメンバイパス率)を測定して評価した。
Evaluation as a lumen bypass agent of the present invention was performed by the following method.
(Evaluation of protective property of the first stomach) The gastric juice is obtained by sucking the first gastric fluid from the cow's mouth through the tube from the middle layer of the first stomach to the vicinity of the lower layer. Immediately after obtaining the first gastric juice, the rumen bypass agent is immersed in 900 mL of the first gastric juice and stirred at 40 ° C. for 16 hours. After stirring, all the rumen bypass agents used in this test were collected, and the residual rate of biologically active substances (lumen bypass rate) was measured and evaluated.
(第4胃の溶出性の評価)上記の方法で採取した第1胃液900mLにルーメンバイパス剤を浸漬し、40℃で16時間攪拌する。攪拌後、この試験に供したルーメンバイパス剤をすべて回収し、第4胃液に相当するClark-Lubs緩衝液900mLに浸漬した。これを37℃で2時間攪拌した後に溶出した生物学的活性物質を測定して評価した。Clark-Lubs緩衝液:塩化カリウム3.73g、塩酸2.1mLを水に溶解した緩衝液。 (Evaluation of dissolution property of the fourth stomach) The rumen bypass agent is immersed in 900 mL of the first gastric juice collected by the above method and stirred at 40 ° C. for 16 hours. After stirring, all of the rumen bypass agent used in this test was collected and immersed in 900 mL of Clark-Lubs buffer corresponding to the fourth gastric juice. This was stirred for 2 hours at 37 ° C., and the biologically active substance eluted was measured and evaluated. Clark-Lubs buffer: A buffer solution in which 3.73 g of potassium chloride and 2.1 mL of hydrochloric acid are dissolved in water.
(小腸の溶出性の評価)第4胃液溶出率測定後、この試験に供したルーメンバイパス剤をすべて回収し、小腸液に相当する緩衝液900mLに浸漬した。これを37℃で7時間攪拌した後に溶出した生物学的活性物質を測定して評価した。 (Evaluation of dissolution property of the small intestine) After measuring the dissolution rate of the fourth gastric juice, all the rumen bypass agents used in this test were collected and immersed in 900 mL of a buffer solution corresponding to the small intestinal fluid. This was stirred at 37 ° C. for 7 hours, and the biologically active substance eluted was measured and evaluated.
菜種硬化油1626g、レシチン90g及びステアリン酸150gを溶融混合して80℃に保温した後、この溶融混合液に粒径を調整したリジン塩酸塩(平均粒径約50μm)1125g及びプロピオン酸カルシウム(防腐剤)9gを加えて均一に分散し噴射用溶融液とした。その噴射用溶融液を空気中に噴射し、0.5〜2.0mmの球状に固化したルーメンバイパス剤を得た。 1626 g of rapeseed oil, 90 g of lecithin, and 150 g of stearic acid were melt-mixed and kept at 80 ° C., and then 1125 g of lysine hydrochloride (average particle size of about 50 μm) adjusted in particle size and calcium propionate (preservative) 9 g) was added and dispersed uniformly to obtain a melt for injection. The melt for spraying was sprayed into the air to obtain a lumen bypass agent solidified into a spherical shape of 0.5 to 2.0 mm.
菜種硬化油1626g、レシチン90g及びステアリン酸150gを溶融混合して80℃に保温した後、この溶融混合液に粒径を調整したリジン塩酸塩(平均粒径約50μm)1125g及びプロピオン酸ナトリウム(防腐剤)9gを加えて均一に分散し、実施例1と同様に製造してルーメンバイパス剤を得た。 1626 g of rapeseed oil, 90 g of lecithin and 150 g of stearic acid were melt-mixed and kept at 80 ° C., and then 1125 g of lysine hydrochloride (average particle size of about 50 μm) adjusted in particle size and sodium propionate (preservative) Agent) 9 g was added and dispersed uniformly, and the same production as in Example 1 was carried out to obtain a lumen bypass agent.
パーム硬化油1517g、レシチン90g及びステアリン酸150gを溶融混合して80℃に保温した後、この溶融混合液に粒径を調整したリジン塩酸塩(平均粒径約50μm)1125g、プロピオン酸カルシウム(防腐剤)18g及び炭酸カルシウム100gを加えて均一に分散し、実施例1と同様に製造してルーメンバイパス剤を得た。 1517 g of hydrogenated palm oil, 90 g of lecithin, and 150 g of stearic acid were melt-mixed and kept at 80 ° C., and then 1125 g of lysine hydrochloride (average particle size of about 50 μm) whose particle size was adjusted to this molten mixture, calcium propionate (preservative) Agent) 18 g and calcium carbonate 100 g were added and dispersed uniformly, and the same production as in Example 1 was carried out to obtain a rumen bypass agent.
菜種硬化油1608g、レシチン90g及びステアリン酸150gを溶融混合して80℃に保温した後、この溶融混合液に粒径を調整したリジン塩酸塩(平均粒径約50μm)1125g及びプロピオン酸カルシウム(防腐剤)27gを加えて均一に分散し、実施例1と同様に製造してルーメンバイパス剤を得た。 1608 g of rapeseed hydrogenated oil, 90 g of lecithin and 150 g of stearic acid were melt-mixed and kept at 80 ° C., and then 1125 g of lysine hydrochloride (average particle size of about 50 μm) adjusted in particle size and calcium propionate (preservative) Agent) 27 g was added and dispersed uniformly, and the same procedure as in Example 1 was carried out to obtain a lumen bypass agent.
菜種硬化油1517g、レシチン90g及びステアリン酸150gを溶融混合して80℃に保温した後、この溶融混合液に粒径を調整したタウリン(平均粒径約50μm)1125g、プロピオン酸カルシウム(防腐剤)18g及び炭酸カルシウム100gを加えて均一に分散し、実施例1と同様に製造してルーメンバイパス剤を得た。 1517 g of hardened rapeseed oil, 90 g of lecithin and 150 g of stearic acid were melt-mixed and kept at 80 ° C., and then 1125 g of taurine (average particle size of about 50 μm) whose particle size was adjusted to this molten mixture, calcium propionate (preservative) 18 g and 100 g of calcium carbonate were added and dispersed uniformly and produced in the same manner as in Example 1 to obtain a rumen bypass agent.
(比較例1)
菜種硬化油1635g、レシチン90g及びステアリン酸150gを溶融混合して80℃に保温した後、この溶融混合液に粒径を調整したリジン塩酸塩(平均粒径約50μm)1125gを加えて均一に分散し、実施例1と同様に製造してルーメンバイパス剤を得た。
(Comparative Example 1)
1635 g of rapeseed oil, 90 g of lecithin and 150 g of stearic acid were melt-mixed and kept at 80 ° C., and then 1125 g of lysine hydrochloride (average particle size of about 50 μm) with adjusted particle size was added to this melt and dispersed uniformly. And it manufactured like Example 1, and obtained the rumen bypass agent.
(比較例2)
パーム硬化油1535g、レシチン90g及びステアリン酸150gを溶融混合して80℃に保温した後、この溶融混合液に粒径を調整したリジン塩酸塩(平均粒径約50μm)1125g及び炭酸カルシウム100gを加えて均一に分散し、実施例1と同様に製造してルーメンバイパス剤を得た。
(Comparative Example 2)
After 1535 g of hardened palm oil, 90 g of lecithin and 150 g of stearic acid were melt-mixed and kept at 80 ° C., 1125 g of lysine hydrochloride (average particle size of about 50 μm) whose particle size was adjusted and 100 g of calcium carbonate were added to the melt mixture. Were uniformly dispersed and produced in the same manner as in Example 1 to obtain a rumen bypass agent.
(比較例3)
菜種硬化油1716g及びステアリン酸150gを溶融混合して80℃に保温した後、この溶融混合液に粒径を調整したリジン塩酸塩(平均粒径約50μm)1125g、プロピオン酸カルシウム(防腐剤)9gを加えて均一に分散し、実施例1と同様に製造してルーメンバイパス剤を得た。
(Comparative Example 3)
1716 g of rapeseed oil and 150 g of stearic acid were melt-mixed and kept at 80 ° C., and then 1125 g of lysine hydrochloride (average particle size of about 50 μm) with adjusted particle size was added to this melt and 9 g of calcium propionate (preservative). Was added and dispersed uniformly to produce a lumen bypass agent in the same manner as in Example 1.
(比較例4)
菜種硬化油1626g、レシチン90g及びステアリン酸150gを溶融混合して80℃に保温した後、この溶融混合液に粒径を調整したリジン塩酸塩(平均粒径約200μm)1125g、プロピオン酸カルシウム(防腐剤)9gを加えて均一に分散し、実施例1と同様に製造してルーメンバイパス剤を得た。
(Comparative Example 4)
1626 g of rapeseed hydrogenated oil, 90 g of lecithin and 150 g of stearic acid were melt-mixed and kept at 80 ° C., then 1125 g of lysine hydrochloride (average particle size of about 200 μm) adjusted in particle size was added to this molten mixture, calcium propionate (preservative) Agent) 9 g was added and dispersed uniformly, and the same production as in Example 1 was carried out to obtain a lumen bypass agent.
(比較例5)
菜種硬化油1535g、レシチン90g及びステアリン酸150gを溶融混合して80℃に保温した後、この溶融混合液に粒径を調整したタウリン(平均粒径約50μm)1125g及び炭酸カルシウム100gを加えて均一に分散し、実施例1と同様に製造してルーメンバイパス剤を得た。
(Comparative Example 5)
1535 g of rapeseed oil, 90 g of lecithin and 150 g of stearic acid were melt-mixed and kept at 80 ° C., and then 1125 g of taurine (average particle size of about 50 μm) with adjusted particle size and 100 g of calcium carbonate were added uniformly to this melted mixture. And was produced in the same manner as in Example 1 to obtain a rumen bypass agent.
実施例を表1、比較例を表2にまとめた。実施例と比較例より防腐剤を含有したルーメンバイパス剤が反すう動物の第1胃での保護性(ルーメンバイパス率)において良好な結果を示した。 Examples are shown in Table 1 and Comparative Examples are shown in Table 2. From the examples and comparative examples, the rumen bypass agent containing a preservative showed good results in ruminant protection in the rumen (lumen bypass rate).
以上のように、生物学的活性物質を、A)硬化した動物性油脂、硬化した植物性油脂、炭素数12〜22個を有する直鎖又は分岐状の飽和又は不飽和の脂肪族モノカルボン酸、脂肪酸エステル、ロウ及びワックスより選択される少なくとも1種の被覆剤、B)レシチン及びC)プロピオン酸又はその塩、ソルビン酸又はその塩、安息香酸又はその塩、デヒドロ酢酸又はその塩、パラオキシ安息香酸エステル類、イマザリル、チアベンダゾール、オルトフェニルフェノール、オルトフェニルフェノールナトリウム及びジフェニルより選択される少なくとも1種の防腐剤、よりなる被覆組成物で被覆したことを特徴とした反すう動物用ルーメンバイパス剤は優れた保護性(高いルーメンバイパス率)を有し、かつ第4胃以降の下部消化器官での放出性も優れていることが判明した。
As described above, the biologically active substance is divided into A) hardened animal oil and fat, hardened vegetable oil and fat, straight chain or branched saturated or unsaturated aliphatic monocarboxylic acid having 12 to 22 carbon atoms. At least one coating agent selected from fatty acid esters, waxes and waxes, B) lecithin and C) propionic acid or a salt thereof, sorbic acid or a salt thereof, benzoic acid or a salt thereof, dehydroacetic acid or a salt thereof, paraoxybenzoic acid A rumen bypass agent for ruminants characterized by being coated with a coating composition comprising at least one preservative selected from acid esters, imazalyl, thiabendazole, orthophenylphenol, sodium orthophenylphenol and diphenyl. Protection (high lumen bypass rate) and release in the lower digestive tract after the 4th stomach It has been found that is also excellent sex.
Claims (7)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004335286A JP3728738B1 (en) | 2004-11-19 | 2004-11-19 | Rumen bypass for ruminants |
PCT/JP2005/008074 WO2005104868A1 (en) | 2004-04-30 | 2005-04-27 | Feed additive composition for ruminant, feed containing the same and process for producing feed additive composition for ruminant |
CA2556781A CA2556781C (en) | 2004-04-30 | 2005-04-27 | Feed additive composition for ruminant, feed containing the same and process for producing feed additive composition for ruminant |
US10/588,969 US8642070B2 (en) | 2004-04-30 | 2005-04-27 | Feed additive composition for ruminants, and feed containing the same, and method of fabricating such feed additive composition for ruminants |
EP05736499A EP1741347A4 (en) | 2004-04-30 | 2005-04-27 | Feed additive composition for ruminant, feed containing the same and process for producing feed additive composition for ruminant |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004335286A JP3728738B1 (en) | 2004-11-19 | 2004-11-19 | Rumen bypass for ruminants |
Publications (2)
Publication Number | Publication Date |
---|---|
JP3728738B1 true JP3728738B1 (en) | 2005-12-21 |
JP2006141270A JP2006141270A (en) | 2006-06-08 |
Family
ID=35588866
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004335286A Expired - Lifetime JP3728738B1 (en) | 2004-04-30 | 2004-11-19 | Rumen bypass for ruminants |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3728738B1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009122750A1 (en) | 2008-04-03 | 2009-10-08 | 味の素株式会社 | Feed additive composition for ruminants and method of producing the same |
EP2407033A1 (en) | 2006-10-04 | 2012-01-18 | Ajinomoto Co., Inc. | Feed additive composition for ruminants and method of producing the same |
WO2016105954A1 (en) * | 2014-12-22 | 2016-06-30 | Archer Daniels Midland Company | Liquid products having increased solids concentrations |
CN111657396A (en) * | 2020-07-08 | 2020-09-15 | 厦门庚能新材料技术有限公司 | Bioactive additive for rumen bypass of ruminant, preparation process and feed thereof |
CN116369435A (en) * | 2023-03-21 | 2023-07-04 | 光明牧业有限公司 | A gamma-aminobutyric acid preparation and its preparation method and application |
JP2023110820A (en) * | 2022-01-28 | 2023-08-09 | 全国農業協同組合連合会 | Method for reducing, inhibiting, or improving condition or symptom of cattle related to transportation |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008306931A (en) * | 2007-06-12 | 2008-12-25 | All In One:Kk | Livestock feed |
JP2011125217A (en) | 2008-04-03 | 2011-06-30 | Ajinomoto Co Inc | Ruminant feed additive composition containing acidic or neutral amino acid, and method for producing the same |
WO2009139468A1 (en) * | 2008-05-16 | 2009-11-19 | 出光興産株式会社 | Coccidiosis control agent and feed containing the same |
CA3095317A1 (en) * | 2018-03-29 | 2019-10-03 | Ajinomoto Co., Inc. | Additive composition for ruminant feeds |
JP7423999B2 (en) * | 2019-11-19 | 2024-01-30 | 日油株式会社 | Feed composition, coated particles, method for producing feed composition |
-
2004
- 2004-11-19 JP JP2004335286A patent/JP3728738B1/en not_active Expired - Lifetime
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2407033A1 (en) | 2006-10-04 | 2012-01-18 | Ajinomoto Co., Inc. | Feed additive composition for ruminants and method of producing the same |
WO2009122750A1 (en) | 2008-04-03 | 2009-10-08 | 味の素株式会社 | Feed additive composition for ruminants and method of producing the same |
WO2016105954A1 (en) * | 2014-12-22 | 2016-06-30 | Archer Daniels Midland Company | Liquid products having increased solids concentrations |
CN111657396A (en) * | 2020-07-08 | 2020-09-15 | 厦门庚能新材料技术有限公司 | Bioactive additive for rumen bypass of ruminant, preparation process and feed thereof |
JP2023110820A (en) * | 2022-01-28 | 2023-08-09 | 全国農業協同組合連合会 | Method for reducing, inhibiting, or improving condition or symptom of cattle related to transportation |
JP7603325B2 (en) | 2022-01-28 | 2024-12-20 | 全国農業協同組合連合会 | Methods for reducing, preventing or ameliorating a transport-related condition or symptom in cattle |
CN116369435A (en) * | 2023-03-21 | 2023-07-04 | 光明牧业有限公司 | A gamma-aminobutyric acid preparation and its preparation method and application |
Also Published As
Publication number | Publication date |
---|---|
JP2006141270A (en) | 2006-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8642070B2 (en) | Feed additive composition for ruminants, and feed containing the same, and method of fabricating such feed additive composition for ruminants | |
US12082595B2 (en) | Rumen protected products | |
CN102985078B (en) | For the microgranule of the oral delivery of animal | |
JP3728738B1 (en) | Rumen bypass for ruminants | |
JP6685407B2 (en) | Compositions for improving nitrogen utilization in ruminants | |
JP2015524664A (en) | How to protect active ingredients from degradation during pelletization | |
JP2005312380A (en) | Rumen bypass agent for ruminant, feed of the same and method for producing the rumen bypass agent | |
US20250009672A1 (en) | Compositions and methods for improving nitrogen utilization in a ruminant | |
JPS6137054A (en) | Particle for feed additive | |
JPH0523114A (en) | Feed additive composition for ruminant | |
JPS61195653A (en) | Particle for ruminant | |
JPS59198946A (en) | Feed additive | |
JP2645497B2 (en) | Ruminant feed additives | |
US12121042B2 (en) | Additive composition for ruminant feeds | |
JP2533352B2 (en) | Feed additives for ruminants | |
JPS60168350A (en) | Feed additive passing through rumen of ruminant | |
JPH02163043A (en) | Feed additive for ruminant | |
JPH0829052B2 (en) | Feed additives for ruminants | |
JPH0521B2 (en) | ||
JPH0767547A (en) | Feed addition composition for ruminant | |
JPH03280842A (en) | Feed additive for ruminant | |
JPH03280844A (en) | Feed additive for ruminant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TRDD | Decision of grant or rejection written | ||
A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20050908 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20050920 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20050829 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20050922 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 3728738 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081014 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111014 Year of fee payment: 6 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111014 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131014 Year of fee payment: 8 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20141014 Year of fee payment: 9 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |